首页|EXO1分子在宫颈癌患者诊断和预后中的价值

EXO1分子在宫颈癌患者诊断和预后中的价值

扫码查看
目的:研究EXO1 分子在宫颈癌诊断和预后中的作用.方法:从TCGA数据库下载309 个宫颈癌相关数据,通过构建列线图、GSEA富集分析、GO和KEGG富集分析、Spearman秩相关系数法分析等生物信息学分析方法分析EXO1 分子在宫颈癌发展中的作用.结果:差异表达分析结果显示EXO1 的表达在肿瘤组显著高于正常对照组(P<0.01);生存分析显示宫颈癌患者中EXO1 高表达组比低表达组总生存率低;单因素分析显示宫颈癌的发生与N分期、主要治疗方式、EXO1 表达相关(P<0.05);富集分析结果显示在EXO1 高表达的患者中,表皮细胞分化、内分泌过程调控和酶激活等信号通路相关的基因集均得到富集.Spearman相关系数分析显示EXO1 的表达与巨噬细胞、中性粒细胞、Th1 细胞、Th17 细胞、调节性T细胞、B细胞等的丰度呈负相关,与辅助性T细胞和记忆型T细胞的丰度呈正相关(P<0.05).结论:EXO1 可能是宫颈癌患者诊断策略的潜在靶点;EXO1 可以作为宫颈癌潜在的预后生物标志物和治疗靶点.
The Value of EXO1 Molecule in the Diagnosis and Prognosis of Cervical Cancer Patients
Objective To investigate the value of EXO1 molecule in diagnosis and prognosis of cervical cancer.Methods A total of 309 cervical cancer-associated datasets were downloaded from the TCGA database,and the role of the EXO1 mole-cule in cervical cancer development was analyzed using bioinformatics analysis methods such as constructing column charts,GSEA enrichment analysis,GO and KEGG enrichment analysis,and Spearman rank correlation coefficient analysis.Re-sults The differential expression analysis revealed a significant elevation of EXO1 expression in the tumor group compared to the normal control group(P<0.01).Survival analysis indicated a lower overall survival rate in cervical cancer patients with high expression of EXO1 as opposed to those with low expression.Univariate analysis demonstrated the occurrence of cervi-cal cancer was related to N stage,primary treatment method,and EXO1 expression(P<0.05).Enrichment analysis results demonstrated that gene sets related to signaling pathways such as epidermal cell differentiation,regulation of endocrine processes,and enzyme activation were enriched in patients with high expression of EXO1.Spearman correlation analysis un-covered a negative correlation between the expression of EXO1 and the abundance of macrophages,neutrophils,Th1 cells,Th17 cells,regulatory T cells,and B cells,while it exhibited a positive correlation with helper T cells and memory T cells(P<0.05).Conclusion EXO1mayserveasapotentialtargetforthediagnosticstrategyofcervicalcancerpatients.Moreo-ver,it can also be considered as a potential prognostic biomarker and therapeutic target for cervical cancer.

EXO1Cervical cancerDiagnosisPrognostic marker

曹伟良

展开 >

湖北医药学院附属襄阳市第一人民医院检验科,湖北 襄阳 441000

EXO1 宫颈癌 诊断 预后标志物

湖北省自然科学基金创新发展联合基金

2022CFD107

2024

湖北医药学院学报
湖北医药学院

湖北医药学院学报

影响因子:0.504
ISSN:1006-9674
年,卷(期):2024.43(2)
  • 16